Navinci Diagnostics
life science company
Navinci Diagnostics has raised €8.5M across 1 funding round from 4 investors, most recently a Series A round in Jul 2022. Based in Uppsala, Sweden; active in Healthtech. Data as of 4 Nov 2026.
Uppsala, Swedennavinci.se ↗
Total raised
€8.5M
€8,467,401
Funding rounds
1
Investors
4
distinct backers
Active since
2022-07
latest 2022-07
Funding by year
EUR raised per yearNavinci Diagnostics — funding by year — interactive chart.
Data table
| Navinci Diagnostics — funding by year | |
|---|---|
| 2022 | €8.5M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Past typical raise window
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-07-12 | Series A | €8.5M | Beijer Ventures,Landegren Gene Technology,Nexttobe,Segulah Medical Acceleration | View deal → |
Related news
- Navinci Diagnostics Closes SEK 90M Series A Financingfinsmes.com · 2022-07
Similar companies
same sector, similar size- Flow neuroscience€9.9MSweden · Healthtech
- Varden.se€4.9MSweden · Healthtech
- Mendi€8.0MSweden · Healthtech
- OnDosis€9.1MSweden · Healthtech
- Collective Minds Radiology€7.1MSweden · Healthtech
- Medoma€6.0MSweden · Healthtech
Global coverage: FundingData